Export 7 results:
Filters: Author is Susan C Tilton and Type is Journal Article  [Clear All Filters]
Journal Article
Monica L. Vermillion Maier, Siddens LK, Pennington J, Uesugi S, Anderson KA, Tidwell LG, Tilton SC, Ognibene TJ, Turteltaub K, Smith J et al..  2022.  Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [C]-BaP.. Environ Int. 159:107045.
Monica L. Vermillion Maier, Siddens LK, Pennington J, Uesugi S, Tilton SC, Vertel EA, Anderson KA, Tidwell LG, Ognibene TJ, Turteltaub K et al..  2023.  Benzo[a]pyrene toxicokinetics in humans following dietary supplementation with 3,3'-diindolylmethane (DIM) or Brussels sprouts.. Toxicol Appl Pharmacol. :116377.
Monica L. Vermillion Maier, Siddens LK, Pennington J, Uesugi S, Labut EM, Vertel EA, Anderson KA, Tidwell LG, Tilton SC, Ognibene TJ et al..  2023.  Impact of phenanthrene co-administration on the toxicokinetics of benzo[a]pyrene in humans. UPLC-accelerator mass spectrometry following oral microdosing.. Chem Biol Interact. 382:110608.
Hummel JM, Madeen E, Siddens LK, Uesugi S, McQuistan T, Anderson KA, Turteltaub K, Ognibene TJ, Bench G, Krueger SK et al..  2018.  Pharmacokinetics of [C]-Benzo[a]pyrene (BaP) in humans: Impact of Co-Administration of smoked salmon and BaP dietary restriction.. Food Chem Toxicol. 115:136-147.
Goodale BC, Tilton SC, Corvi MM, Wilson GR, Janszen DB, Anderson KA, Waters KM, Tanguay RL.  2013.  Structurally distinct polycyclic aromatic hydrocarbons induce differential transcriptional responses in developing zebrafish.. Toxicol Appl Pharmacol. 272(3):656-70.
Geier M, D Minick J, Truong L, Tilton SC, Pande P, Anderson KA, Teeguarden JG, Tanguay RL.  2018.  Systematic developmental neurotoxicity assessment of a representative PAH Superfund mixture using zebrafish.. Toxicol Appl Pharmacol.
Madeen E, Siddens LK, Uesugi S, McQuistan T, Corley RA, Smith J, Waters KM, Tilton SC, Anderson KA, Ognibene TJ et al..  2019.  Toxicokinetics of benzo[a]pyrene in humans: Extensive metabolism as determined by UPLC-accelerator mass spectrometry following oral micro-dosing.. Toxicol Appl Pharmacol. 364:97-105.